🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Rectal Cancer Patients

AI-Assisted Chemotherapy Side Effect Management NCT07198581NA1 site📍 Incheon Incheon St.Mary's Hospital · Tests: LLM-assisted chemotherapy side effect management DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer NCT06275958Phase 336 sites📍 's-Hertogenbosch📍 Alkmaar📍 Amstelveen Leiden University Medical Center · Tests: Doublet Chemotherapy, Standard Dose (100%), Doublet Chemotherapy, Dose-reduced (75%), Monotherapy, Standard Dose (100%)… Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer NCT06307548Phase 1, Phase 21 site📍 Buffalo Roswell Park Cancer Institute · Tests: Aminolevulinic Acid, Biospecimen Collection, Computed Tomography, Fluorescence-Guided Surgery, Magnetic Resonance Imagi… Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery NCT03051464Phase 2, Phase 34 sites📍 Dallas📍 Montreal📍 Montreal Sir Mortimer B. Davis - Jewish General Hospital · Tests: Complete responders and Non-complete responders, Chemoradiation + EBRT Boost, Chemoradiation + HDRBT Boost Colorectal Cancer Real-world Outcomes Study of Survival With Immunomodulator Plus Standard Anti-cancer Therapies NCT07703709n/a1 site📍 Taichung Chou-Chen Chen Sacituzumab Govitecan in Metastatic Colorectal Cancer NCT06243393Phase 2, Phase 31 site📍 Heidelberg University Hospital Heidelberg · Tests: Sacituzumab Govitecan (SG), Physicians Choice (PhC). A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI NCT07543744Phase 126 sites📍 Arkhangelsk📍 Istra📍 Ivanovo R-Pharm · Tests: RPH-030, Vectibix®, Irinotecan, Calcium Folinate, Fluorouracil CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Devimistat, Fluorouracil, Gemcitabine Hydrochloride Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites📍 Scottsdale📍 La Jolla📍 Stanford BioEclipse Therapeutics · Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients NCT07114627n/a1 site📍 Rotterdam Erasmus Medical Center · Tests: Blood sampling for pharmacokinetics Evaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal Cancer NCT07171554NA1 site📍 Lørenskog Oncosyne AS · Tests: µCAN drug screen test, Standard-of-Care Therapy TT-702 in Patients With Advanced Solid Tumours. NCT05272709Phase 1, Phase 23 sites📍 London📍 Manchester📍 Southampton Cancer Research UK · Tests: TT-702, Anti-PD-1 and PD-L1 agent KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors NCT06026410Phase 138 sites📍 Phoenix📍 Tucson📍 Los Angeles Kura Oncology, Inc. · Tests: Darlifarnib, Cabozantinib, Adagrasib Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer NCT06530303Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: Tumor Infiltrating Lymphocytes (TIL), Cyclophosphamide, Fludarabine, Interleukin-2, Pembrolizumab JS212 Combination Therapies in Metastatic Colorectal Cancer NCT07503756Phase 21 site📍 Shanghai Shanghai Junshi Bioscience Co., Ltd. · Tests: JS212, Capecitabine, Bevacizumab, Oxaliplatin, JS207 Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial] NCT07071961Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Regorafenib (CT), Lorigerlimab Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients NCT07673861NA1 site📍 London Royal Marsden NHS Foundation Trust · Tests: Marsden360 ctDNA test and GTAB review Nanoliposomal Irinotecan, Oxaliplatin Plus Capecitabine As Conversion Therapy of Locally Advanced Colorectal Cancer NCT06405139Phase 21 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Nanoliposomal Irinotecan, Oxaliplatin plus Capecitabine Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy NCT04094454NA1 site📍 Heidelberg Juergen Debus · Tests: special tampon with a diameter of 28mm, standard tampon with a diameter of 12-13mm Effect of Lidocaine on Postoperative Pain and Long-term Survival in Elderly Patients Undergoing Colorectal Surgery NCT06405776NA1 site📍 Sichuan West China Hospital · Tests: lidocaine, Placebo Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer NCT06584318NA1 site📍 Beijing Capital Medical University · Tests: Intermittent hypoxia intervention Optimizing Patient Treatment With EPA-enriched Nutrition, a Randomised Control Trial NCT07255066NA4 sites📍 Oslo📍 Edinburgh📍 Gateshead University of Edinburgh · Tests: Fortimel Forticare Sensations Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial NCT06563388Phase 31 site📍 Buffalo Roswell Park Cancer Institute · Tests: Stereotactic Ablative Radiotherapy, Best Practice Role of MRI in the Evaluation of Hepatic Metastases of Colorectal Cancer NCT05950503n/a1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Hepatic MRI Immunotherapy in Patients With Early dMMR Rectal Cancer NCT05732389Phase 25 sites📍 Aalborg📍 Aarhus📍 Copenhagen Odense University Hospital · Tests: Nivolumab, Ipilimumab Watch and Wait as Treatment for Patients With Rectal Cancer NCT03125343NA2 sites📍 Gothenburg📍 Stockholm Sahlgrenska University Hospital · Tests: endoscopy, Surgery, MRI PRIORITY-CONNECT 2 Trial NCT06976710NA31 sites📍 Coffs Harbour📍 Newcastle📍 Newcastle Surgical Outcomes Research Centre (SOuRCe) · Tests: Preoperative Exercise, Postoperative Exercise, Preoperative Nutrition, Postoperative Nutrition, Preoperative Psychology Prospective Monocentric Study Evaluating the Circulating NK Cells Phenotype and the ImmunoScore® in Patients With Non Metastatic Rectal Cancer NCT06536127NA1 site📍 Avignon Institut Sainte Catherine · Tests: Blood samples Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors NCT04771520Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Avapritinib Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial NCT06496256NA13 sites📍 Chandler📍 Santa Barbara📍 Boca Raton Palette Life Sciences, Inc. · Tests: Barrigel, Transrectal Ultrasound
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy